Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review

Clin Rheumatol. 2011 Oct;30(10):1265-75. doi: 10.1007/s10067-011-1828-9. Epub 2011 Aug 11.

Abstract

The objective of this study is to systematically review the role of positron emission tomography (PET) and PET/computed tomography (PET/CT) with fluorine-18-fluorodeoxyglucose (FDG) in patients with large-vessel vasculitis (LVV). A comprehensive literature search of published studies through April 2011 in PubMed/MEDLINE and Scopus databases regarding whole-body FDG-PET and PET/CT in patients with LVV was performed. We identified 32 studies including 604 LVV patients. The main findings of these studies are presented. The conclusions are the following: (1) FDG-PET and PET/CT are useful imaging methods in the initial diagnosis and in the assessment of activity and extent of disease in patients with LVV; (2) the correlation between FDG-PET findings and serological levels of inflammatory markers, as well as the usefulness of FDG-PET and PET/CT in evaluating treatment response, remains unclear; (3) it appears that there is a superiority of FDG-PET and PET/CT over conventional imaging methods in the diagnosis of LVV, but not in assessing disease activity under immunosuppressive treatment, in predicting relapse or in evaluating vascular complications; and (4) given the heterogeneity between studies with regard to PET analysis and diagnostic criteria, a standardization of the technique is needed.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Male
  • Multimodal Imaging*
  • Positron-Emission Tomography*
  • Predictive Value of Tests
  • Radiopharmaceuticals*
  • Severity of Illness Index
  • Tomography, X-Ray Computed*
  • Treatment Outcome
  • Vasculitis / complications
  • Vasculitis / diagnostic imaging*
  • Vasculitis / drug therapy
  • Whole Body Imaging*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18